GLP-1 Savings Programs That Actually Work: A Complete Guide for 2026

If you've been prescribed a GLP-1 medication like Ozempic, Wegovy, Mounjaro, or Zepbound, you've probably experienced sticker shock at the pharmacy. These life-changing medications can cost $900 to $1,500 per month without insurance coverage. But here's what many people don't realize: there are legitimate savings programs that can dramatically reduce your costs, and some options bring GLP-1 therapy down to $99 per month.

Let's walk through the savings programs that actually work, so you can access the treatment you need without breaking the bank.

Understanding Why GLP-1 Medications Cost So Much

Before diving into savings options, it helps to understand the pricing landscape. Brand-name GLP-1 medications are manufactured by pharmaceutical companies that set list prices based on research costs, manufacturing, and market positioning.

Without insurance or savings programs, you're paying the full retail price. The good news? Very few people actually need to pay that amount. Multiple pathways exist to reduce your costs significantly.

Manufacturer Savings Cards and Coupons

Most GLP-1 manufacturers offer savings cards for eligible patients. These programs can reduce your copay substantially, but they come with specific requirements.

Novo Nordisk Savings Card (Ozempic and Wegovy)

Novo Nordisk offers savings cards that can lower your monthly cost to as little as $25 for up to 24 months. However, you must have commercial insurance that covers the medication, and you cannot use this program if you're on Medicare, Medicaid, or any government insurance.

The card applies to your copay after insurance processes the claim. If your insurance doesn't cover the medication at all, this savings card won't help.

Eli Lilly Savings Card (Mounjaro and Zepbound)

Eli Lilly's savings program works similarly, offering eligible patients savings that bring their copay down to $25 per month. The same restrictions apply: you need commercial insurance coverage, and government insurance beneficiaries don't qualify.

Eli Lilly also has a self-pay program that offers a discounted rate, though it's still significantly higher than other alternatives.

Patient Assistance Programs for Uninsured Patients

If you don't have insurance or your income falls below certain thresholds, manufacturer patient assistance programs (PAPs) may provide your medication for free or at drastically reduced costs.

These programs typically require documentation of your income and insurance status. Application processes can take several weeks, and you'll need to reapply periodically. Your healthcare provider's office can often help with the paperwork.

While these programs are genuine lifelines for qualifying patients, many people fall into a gap: they earn too much to qualify for assistance but can't afford the retail price.

Insurance Coverage: What You Need to Know

Commercial insurance coverage for GLP-1 medications varies widely. Some plans cover these medications for diabetes but not for weight management. Others require prior authorization or step therapy (trying other medications first).

Getting Insurance Approval

If your insurance denies coverage initially, don't give up. Your doctor can submit a letter of medical necessity explaining why this specific medication is appropriate for your health situation. Many denials are overturned on appeal.

Documentation of previous weight loss attempts, related health conditions like prediabetes or high blood pressure, and how excess weight impacts your health can strengthen your case.

Gender Considerations in Coverage

Women seeking GLP-1 medications for weight management may face additional documentation requirements, particularly if they have PCOS or other hormonal conditions. Insurance companies sometimes require proof that other treatments have been attempted first. Men with obesity-related conditions like sleep apnea or fatty liver disease may find it easier to obtain approval when these comorbidities are clearly documented.

Compounded Semaglutide and Tirzepatide: An Affordable Alternative

Here's an option many people don't know about: compounded versions of GLP-1 medications. When there's a shortage of brand-name medications, FDA-registered compounding pharmacies can legally create compounded versions using the same active ingredients.

Compounded semaglutide (the active ingredient in Ozempic and Wegovy) and compounded tirzepatide (the active ingredient in Mounjaro and Zepbound) offer the same therapeutic benefits at a fraction of the cost.

Through telehealth platforms that work with compounding pharmacies, patients can access these medications for $99 to $400 per month, no insurance required. These programs include physician consultations, prescription management, and home delivery.

The medications are prepared in sterile facilities following strict quality standards. While they're not FDA-approved in the same way brand-name drugs are, they use the same active pharmaceutical ingredients and are legal to prescribe and dispense during shortage periods.

Pharmacy Discount Cards and Programs

Discount cards like GoodRx, SingleCare, and others can reduce costs at retail pharmacies. However, for GLP-1 medications, the savings are usually modest, bringing a $1,000 medication down to perhaps $800 or $900.

These cards work best for generic medications. Since GLP-1 medications don't yet have generic versions available, discount cards provide limited relief for most patients.

What Actually Works: A Practical Approach

Here's the honest assessment: if you have commercial insurance that covers GLP-1 medications, use the manufacturer savings card to reduce your copay. If you're uninsured or underinsured, compounded options through telehealth platforms offer the most accessible pricing.

Patient assistance programs work well if you qualify income-wise, but application processes can be lengthy. Pharmacy discount cards provide minimal savings for these specific medications.

The landscape is changing rapidly. More insurance plans are adding coverage as evidence mounts about the metabolic and cardiovascular benefits of GLP-1 therapy. Advocacy for better access continues, particularly for weight management indications.

From the Ozari Care Team

Start by checking every savings option you qualify for, beginning with manufacturer programs if you have commercial insurance. Many of our patients found that persistence with insurance appeals, combined with thorough documentation from their healthcare provider, eventually led to approval. Remember that effective weight management is a long-term commitment, so finding a sustainable cost structure matters as much as the initial savings.

Access Affordable GLP-1 Therapy Today

At Ozari Health, we offer compounded Semaglutide and Tirzepatide starting at $99/month, prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team, licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 25, 2026